Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026)
Envoy Medical (COCH) posted Gains from Investment Securities of $13000.0 for Q1 2026, up 208.33% sequentially from -$12000.0 in Q4 2025, and up 103.09% YoY from $6401.2 in Q1 2025.
Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Envoy Medical has reported Gains from Investment Securities for 6 years, with the latest figure at $13000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 103.09% year-over-year to $13000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$457000.0 (up 58.23% YoY) and the FY2025 annual result came in at -$534000.0, down 29.93% from the prior year.
- Gains from Investment Securities advanced to $13000.0 in Q1 2026 per COCH's latest filing, from -$12000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $693000.0 in Q3 2025 and troughed at -$20.0 million in Q4 2022.
- A 5-year average of -$2.5 million and a median of -$203333.5 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities tumbled 2911.97% in 2022, then soared 291.19% in 2024.
- Over 5 years, Gains from Investment Securities stood at -$20.0 million in 2022, then soared by 94.78% to -$1.0 million in 2023, then advanced by 29.25% to -$740000.0 in 2024, then surged by 98.38% to -$12000.0 in 2025, then surged by 208.33% to $13000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $13000.0, -$12000.0, and $693000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Envoy Medical | 77.89 Mn | 58.22 Mn | -227,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -23,000.00 |
| Jun 30, 2026 | -23,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Mar 31, 2025 | -421,000.00 |
| Mar 31, 2025 | -421,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | -244,000.00 |
| Jun 30, 2024 | -244,000.00 |
| Mar 31, 2024 | 262,000.00 |
| Mar 31, 2024 | 262,000.00 |